Scilex Holding Company Shareholders' Equity
Scilex Holding Company (SCLX) had Shareholders' Equity of -$308.32 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$308.32M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$249.22M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$207.78M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$176.94M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$308.32M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$249.22M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | -$207.78M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$176.94M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$248.99M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | -$211.48M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$192.64M 10-K · filed 2026-04-10 | |
| 2024-09-30 | -$211.32M 10-Q · filed 2025-01-17 | |
| 2024-06-30 | -$214.69M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$189.79M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$172.94M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$162.67M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $10.42M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $11.08M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $36.24M 10-K · filed 2024-03-12 | |
| 2022-09-30 | -$12.00M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | -$10.76M 10-Q · filed 2022-11-04 | |
| 2022-03-31 | -$10.54M 10-Q · filed 2022-11-04 | |
| 2021-12-31 | -$223.88M 10-K · filed 2023-03-07 | -$8.70M 10-K · filed 2022-02-24 |
| 2021-09-30 | -$9.83M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | -$8.39M 10-Q · filed 2022-11-04 | $5.00M 10-Q · filed 2021-08-19 |
| 2021-03-31 | -$8.15M 10-Q · filed 2022-11-04 | $5.00M 10-Q · filed 2021-07-23 |
| 2020-12-31 | $18.72K 10-Q · filed 2022-11-04 | |
| 2020-03-31 | -$5.00K 10-Q · filed 2021-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |